scholarly journals Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

PLoS ONE ◽  
2012 ◽  
Vol 7 (1) ◽  
pp. e29794 ◽  
Author(s):  
Daniel A. Monti ◽  
Edith Mitchell ◽  
Anthony J. Bazzan ◽  
Susan Littman ◽  
George Zabrecky ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Ascorbic Acid ◽  
Phase I ◽  
Metastatic Pancreatic Cancer ◽  
Intravenous Ascorbic Acid

A Phase I Clinical Trial of Ascorbic Acid and Gemcitabine for the Treatment of Metastatic Pancreatic Cancer

2011 ◽  
Vol 51 ◽  
pp. S130
Author(s):  
Jessemae Welsh ◽  
Brett Wagner ◽  
Pamela Zehr ◽  
Daniel Berg ◽  
Thorvardur Halfdanarson ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Clinical Trial ◽  
Ascorbic Acid ◽  
Phase I ◽  
Phase I Clinical Trial ◽  
Metastatic Pancreatic Cancer

scholarly journals Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

2014 ◽  
Vol 12 (1) ◽  
Author(s):  
Alpha A Fowler ◽  
◽  
Aamer A Syed ◽  
Shelley Knowlson ◽  
Robin Sculthorpe ◽  
...  
Keyword(s):  
Ascorbic Acid ◽  
Severe Sepsis ◽  
Phase I ◽  
Intravenous Ascorbic Acid

scholarly journals A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer

2020 ◽  
Vol 26 (19) ◽  
pp. 5092-5101 ◽  
Author(s):  
Michael J. Pishvaian ◽  
Hongkun Wang ◽  
Aiwu Ruth He ◽  
Jimmy J. Hwang ◽  
Brandon G. Smaglo ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase I ◽  
Metastatic Pancreatic Cancer
Sign in / Sign up

Export Citation Format

Share Document